Loading...
XSHE
000739
Market cap3.05bUSD
Jul 09, Last price  
17.84CNY
1D
0.28%
1Q
0.11%
Jan 2017
136.92%
Name

Apeloa Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHE:000739 chart
P/E
23.20
P/S
2.12
EPS
0.77
Div Yield, %
3.95%
Shrs. gr., 5y
-0.43%
Rev. gr., 5y
4.37%
Revenues
9.76b
-18.82%
1,184,228,9111,041,520,3171,228,126,0001,367,853,6941,520,985,2522,813,608,7673,480,088,2173,855,290,0474,232,760,1424,337,941,1874,772,188,8785,551,763,0646,375,980,4987,210,711,3857,879,672,7438,942,618,23210,544,905,37611,474,162,36412,021,863,0299,758,757,576
Net income
891m
-13.62%
53,311,78230,442,82229,058,94434,085,09423,789,27975,631,266137,133,181167,358,829322,164,391208,230,305262,897,088256,592,091370,561,033553,400,771816,730,075955,550,177989,173,6831,055,340,7481,031,121,703890,677,997
CFO
1.23b
+1.81%
159,428,595174,198,82794,568,648208,298,453121,045,562404,624,093335,901,418190,445,544786,637,638441,161,691180,419,814209,799,349832,692,2741,360,066,1901,059,526,132611,748,7281,326,107,3161,031,363,0741,208,753,6831,230,669,957
Dividend
Sep 17, 20250.34835 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical enterprise, specializing in the discovery, development, production, and global distribution of a diverse range of medicinal products. Its market reach spans China and various international territories. The company strategically focuses its product portfolio on several critical medical fields, including cardiovascular and cerebrovascular health, anti-infective treatments, antiviral therapies, and oncology (cancer treatment), alongside other therapeutic categories. Apeloa's offerings encompass finished pharmaceutical preparations, raw material intermediates (active pharmaceutical ingredients and their precursors), and veterinary medicines. These products are primarily recognized and sold under key brands such as Tianliwei, Beshin, Yosemade, and Jutai, among others. Furthermore, the company extends its expertise to other pharmaceutical businesses by providing contract research, development, and manufacturing (CDMO) services. The corporate headquarters for Apeloa Pharmaceutical Co.,Ltd are located in Dongyang, China.
IPO date
May 09, 1997
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT